Confident Pain Management

Treating Pain is at the
Heart of Medicine

Medasense is the developer of a unique technology that objectively monitors and quantifies the patient’s pain response level using artificial intelligence algorithms and a proprietary noninvasive sensor platform.

NOL technology is used to optimize pain management in critical care settings, where anaesthetized patients are unable to communicate.

Interface connectivity is enabled with Philips patient monitors, enabling a consolidated view of changes in pain response level alongside vital signs.

The technology is distributed across Europe exclusively by Medtronic, and by leading partners in other regions.

nol technology

Eliminate guesswork and meet clinical challenges in assessing pain and optimizing analgesia.



Welcome to our online and customized education and training program for clinicians and commercial partners.

Latest News

Medasense Founder and CEO Galit Zuckerman-Stark has been named one of 13 finalists for the EU Prize for Women Innovators 2020.


NOL WEBINAR: Join leading experts in the field as they reveal the latest clinical evidence, insights and emerging applications!


Study validates NOL technology for assessment of pain in mechanically ventilated patients.


Global Distribution Network

Medasense Global Distribution Map

Video Highlights

The essence of Medasense: Guiding critical care clinicians for optimal pain care

Meeting the challenge of intraoperative pain monitoring

Leading clinicians on the importance of monitoring the patient’s pain response level

Clinical Collaborations

1. Meijer, F., Martini, C., Broens, S., Boon, M., Niesters, M., Aarts, L., Olofsen, E., van Velzen, M., Dahan, A. (2019). Nociception-guided versus Standard Care during Remifentanil–Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology, 130(5), 745-755. doi:10.1097/ALN.0000000000002634